PTX3 and pancreatic ductal adenocarcinoma: The sensitivity and specificity values for PTX-3 are more promising than those for the currently used serum biomarker (CA19-9) for pancreatic ductal adenocarcinoma diagnosis (sensitivity range 0.41–0.86 and specificity range 0.33–1 for CA19-9).